AstraZeneca Says Its COVID-19 Vaccine Was 74% Effective In Large US Trial

The Hill (9/30, Scully) reports, “British drugmaker AstraZeneca’s COVID-19 vaccine Vaxzevria has been found to have a 74 percent efficacy in preventing symptomatic disease, according to a report published Wednesday in the New England Journal of Medicine.”...